Evidence map›Paper›PMID 18274840›Full record

GuidelineJournal of hepato-biliary-pancreatic surgery2008

Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors.

Masaru Miyazaki, Tadahiro Takada, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Junji Furuse, Hiroya Saito, Toshio Tsuyuguchi, Kazuo Chijiiwa and 10 more

Open access · bronzeAbstract readPractice GuidelineReview
In one paragraph

Guideline in Journal of hepato-biliary-pancreatic surgery, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Systematic review: should routine resection of the extra-hepatic bile duct be performed in gallbladder cancer?Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Pooled it
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Secretin-Enhanced MRCP: How and Why-AJR. American journal of roentgenology · 2021
    Review
  14. Review
  15. Review
  16. Review
  17. Pancreaticobiliary maljunction and biliary cancer.Journal of gastroenterology · 2015
    Review
  18. Gallbladder cancer: Clinical and pathological approach.World journal of clinical cases · 2014
    Review
  19. Actual status of clinical diagnosis in patients with primary gallbladder cancer associated with adenomyomatosis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2013
    Article
  20. Diagnosis and management of gallbladder cancer.North American journal of medical sciences · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 1 country.

Masaru MiyazakiDepartment of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Tadahiro Takada
Shuichi Miyakawa
Kazuhiro Tsukada
Masato Nagino
Satoshi Kondo
Junji Furuse
Hiroya Saito
Toshio Tsuyuguchi
Kazuo Chijiiwa
Fumio Kimura
Hideyuki Yoshitomi
Satoshi Nozawa
Masahiro Yoshida
Keita Wada
Hodaka Amano
Fumihiko Miura
Japanese Association of Biliary Surgery
Japanese Society of Hepato-Pancreatic Surgery
Japan Society of Clinical Oncology
Chiba University · JPTeikyo University · JPAsahikawa Kosei Hospital · JPFujita Health University · JPHokkaido University · JPNagoya University · JPNational Cancer Center Hospital East · JPUniversity of Miyazaki · JPUniversity of Toyama · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curative resection is the only treatment for biliary tract cancer that achieves long-term survival. However, patients with advanced biliary tract cancer have only a limited prognosis even after radical surgical resection. Thus, to improve the longterm results, the early detection of biliary tract cancer and subsequent cure seem to be essential. The purpose of this study was to review the literature concerning the risk factors for cancerous and precancerous lesions of the biliary tract, and prophylactic surgery for these factors. It has been reported that pancreaticobiliary maljunction (PBM) with bile duct dilatation is a risk factor for gallbladder cancer and bile duct cancer, while PBM without bile duct dilatation is a risk factor for gallbladder cancer. Thus, in the former group, a prophylactic excision of the common bile duct and gallbladder should be recommended, while in the later group, a prophylactic cholecystectomy without bile duct resection may be the appropriate surgical procedure. It has also been reported that primary sclerosing cholangitis (PSC) is a risk factor for cholangiocarcinoma. Patients with PSC often develop advanced cholangiocarcinoma with a poor prognosis. In patients with PSC, therefore, strict follow-up should be recommended. Adenoma and dysplasia have been regarded as precancerous lesions of gallbladder cancer. A polypoid lesion of the gallbladder that is sessile, has a diameter greater than 10 mm, and /or grows rapidly, is highly likely to be cancerous and should be resected. Although gallstones seem to be closely associated with gallbladder cancer, there is no evidence of a direct causal relationship between gallstones and gallbladder cancer. Thus, a cholecystectomy is not advised for asymptomatic cholecystolithiasis. Controversy remains as to whether adenomyomatosis of the gallbladder and porcelain gallbladder are associated with gallbladder cancer. With respect to ampullary carcinoma, adenoma of the ampulla is considered to be a precancerous lesion. This article discusses the risk factors for cancerous and precancerous lesions of the biliary tract and prophylactic treatment for these factors.

Indexed as

Ampulla of VaterBiliary Tract NeoplasmsCarcinomaEvidence-Based MedicineHumansRisk Factors

Identifiers

PMID18274840
PMCPMC2794357
OpenAlexW1964925512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.